The beneficial effect of N-acetylcysteine and ciprofloxacin therapy on the outcome of ischemic fulminant hepatic failure.
Assy
Nimer
N
Liver Clinic, Sieff Government Hospital, P.O.B. 1008, Safed 13100, Israel. assy.n@ziv.health.gov.il
Gefen
Hana
H
Schlesinger
Sorina
S
Hussein
Osamah
O
D000111:Acetylcysteine / Q000627:therapeutic use*; D002939:Ciprofloxacin / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D016166:Free Radical Scavengers / Q000627:therapeutic use*; D006801:Humans; D007511:Ischemia / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D008099:Liver / Q000098:blood supply*; D017114:Liver Failure, Acute / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D008875:Middle Aged; D019384:Nucleic Acid Synthesis Inhibitors / Q000627:therapeutic use*
D016166:Free Radical Scavengers; D019384:Nucleic Acid Synthesis Inhibitors; D002939:Ciprofloxacin; D000111:Acetylcysteine